These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1009531)

  • 1. Levamisole in a phase I trial.
    Lichtenfeld JL; Wiernik PH
    Cancer Treat Rep; 1976 Jul; 60(7):963-4. PubMed ID: 1009531
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adjuvant immunotherapy with levamisole in resected and then irradiated epidermoid bronchial cancer. Randomized study].
    Roeslin N; Lang JM; Wihlm JM; Morand G; Witz JP
    Presse Med; 1984 Jun; 13(23):1461-2. PubMed ID: 6233604
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experiences with levamisole.
    Gross RL
    Adv Exp Med Biol; 1976; 73 PT-A():424-7. PubMed ID: 793353
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 5. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Levamisole.
    Lancet; 1975 Feb; 1(7903):389. PubMed ID: 46527
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of bisantrene for unresectable non-small cell bronchogenic carcinoma: an Illinois Cancer Council study.
    McGuire WP; Blough RR; Cobleigh MA; Johnson CM; Kukla LJ; Lad TE; Lanzotti VJ; Stiff PJ; Zawila P
    Cancer Treat Rep; 1983 Sep; 67(9):841-2. PubMed ID: 6883363
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II clinical trial of diaziquone in bronchogenic carcinoma.
    Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M
    Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma.
    Schulman P; Budman DR; Vinciguerra V; Weiselberg L; Abrams S; Degnan T
    Cancer Treat Rep; 1982 Jan; 66(1):171-2. PubMed ID: 7053253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dosage regimen of levamisole in cancer: is it related to efficacy and safety?
    Amery WK; Butterworth BS
    Int J Immunopharmacol; 1983; 5(1):1-9. PubMed ID: 6341264
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma].
    Rebattu P; Coudert B; Schneider M; Ouabdesselam R; Lentz M; Hanauske A; Chevallierdagger B; Fumoleau P; Chollet P
    Rev Pneumol Clin; 2000 Jun; 56(3):200-3. PubMed ID: 10880946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy and combined chemoradiotherapy procedures in bronchial carcinoma].
    Wolf M; Havemann K
    Internist (Berl); 1994 Aug; 35(8):740-50. PubMed ID: 7525503
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma.
    Coates AS; Fox RM; Woods RL; Levi JA; Tattersall MH
    Cancer Treat Rep; 1982 Jan; 66(1):177-8. PubMed ID: 7053255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.
    Schulman P; Budman DR; Weiselberg L; Vinciguerra V; Degnan TJ
    Cancer Treat Rep; 1983 Oct; 67(10):943-5. PubMed ID: 6684988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Brugia malayi infection with levamisole.
    O'Holohan DR; Zaman V
    J Trop Med Hyg; 1974 May; 77(5):113-5. PubMed ID: 4835326
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Greco A; Prestridge K; Johnson R
    Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind comparison of high and low doses of levamisole in rheumatoid arthritis.
    Pinals RS; Robertson F; Blechman WJ
    J Rheumatol; 1981; 8(6):949-51. PubMed ID: 7328569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.
    Br Med J; 1975 Aug; 3(5981):461-4. PubMed ID: 1098727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant levamisole in the treatment of patients with resectable lung cancer.
    Amery WK
    Ann Clin Res; 1980; 12 Suppl 27():1-83. PubMed ID: 6999969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.